跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 26,690 条关于
“Aptamer Group”
全部
26,690
临床试验
18,040
药物
605
机构
509
资讯
7,536
6个月前
Aptamer Group Launches Radiopharmaceutical Program with Enhanced Stability Profile
去年
Aptamer Group Secures New Development Contracts and Licensing Deal for Synthetic Antibody Alternatives
去年
Aptamer and Invizius Partner to Develop Next-Generation Complement System Therapies Using Synthetic Binders
去年
Bacteria-Assisted Aptamer-Drug Conjugates Enhance Pancreatic Cancer Therapy
3个月前
Aptamer Sciences' Trop2-ApDC Selected for South Korea's National New Drug Development Project
去年
Aptamer Sciences' Liver Cancer Drug, AST-201, Enters Phase 1 Trials in Korea
6年前
ApTOLL: Novel Aptamer-Based Therapy Shows Promise for Acute Ischemic Stroke Treatment
去年
WiNK Therapeutics Targets Diabetes with RNA Aptamer Technology
去年
CAGE Bio Initiates Phase 2 Trial of First-in-Class DNA Aptamer Therapy CGB-600 for Vitiligo Treatment
去年
FDA Grants Orphan Drug and Rare Pediatric Disease Designations to HKBU's Aptamer for X-Linked Hypophosphatemia
第 1 页,共 754 页
上一页
下一页